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A B S T R A C T
The evidence on potentially greater benefits of psychoanalysis (PA) vs. long-term psychodynamic psychotherapy
(LPP) is scarce. This study compared the effectiveness of PA and LPP on personality and social functioning during
a 10-year follow-up from the beginning of the treatments. The eligible patients, 41 self-selected for PA and 128
assigned to LPP, were 20–45 years of age and had anxiety or mood disorder. Outcomes were analyzed using ten
standard measures of personality and social functioning, carried out 5–9 times during the follow-up. Different
change patterns by time in PA and LPP emerged, suggesting less benefit of PA during the first years of follow-up
and more benefit in most outcomes thereafter. Greater post-treatment improvement in PA than in LPP was seen
up to 1–2 years after PA had ended in more mature defense style (DSQ), level of personality organization (LPO),
more positive self-concept (SASB), more improved social adjustment (SAS-SR) and sense of coherence (SOC).
However, at the 10-year follow-up the differences were non-significant. In conclusion, PA may give some ad-
ditional benefits when long-term aims are linked to personality and social functioning. The relatively small
differences and higher costs in comparison to LPP may restrict the feasibility of PA.
1. Introduction
There is increasing evidence from clinical trials that long-term
psychodynamic psychotherapy (LPP) has some additional benefits in
comparison to short-term therapies for patients with anxiety and de-
pressive disorders, by producing more improvement in symptoms, work
ability, personality functioning and endured remission during a long
follow-up (Huber et al., 2012; Knekt et al., 2013, 2016). Even more
than LPP, psychoanalysis (PA) has been suggested as a treatment option
when the patient has pervasive personal suffering due to devel-
opmentally induced psychological problems and when the expectations
from the treatment are linked to long-term goals related to personality
growth, restructuring of personality organization, and lessening vul-
nerability to life stresses (American Psychiatric Association, 1985;
Gabbard et al., 2002).
In line with this, symptom change, primarily and alone, is a rather
crude indicator of therapeutic benefits when comparing the effective-
ness of such an intensive and personally deep process as PA with other
therapies (Fonagy, 2003). Rather, as the treatment requires exceptional
commitment from both the patient and the analyst, profound changes
in personality and social functioning – in addition to symptomatic im-
provement – are expected to occur, to last and even continue to develop
several years after the treatment (Bachrach et al., 1991).
There are similarities and differences in the technique and aims of
LPP and PA. They share the common elements of the psychoanalytic
way to listen, understand and to utilize the basic techniques of both,
such as drawing the patient's attention to wishes, feelings or ideas that
the patient may not be aware of, using clarification and various modes
of interpretation (Seybert et al., 2011). However, in PA, the greater
intensity, dosage and length of the treatment, and the utmost goal of
developing a self-analytic function, i.e. greater capacity to carry on
analytic work by oneself, have been claimed to be essential
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(Busch, 2014). Only little research comparing the effectiveness of LPP
and PA is available in the treatment of patients with anxiety and de-
pressive disorders (deMaat et al., 2013). A German trial comparing a
relatively low intensity LPP and PA showed greater effects in PA than
LPP during a 3-year follow-up in personality functioning (Huber et al.,
2013). In a Swedish cohort study more improvement was found in PA
than in LPP in personality functioning and symptoms, which further
improved during a 3-year follow-up after PA (Sandell et al., 2000).
Greater improvement in the self-analytic function and in the capacity to
actively confront and contain difficult emotions, representing aspects of
personality functioning, have been suggested to be key factors of the
additional benefits of PA (Falkenström et al., 2005).
In the Helsinki Psychotherapy Study (HPS), the benefits of PA in
psychiatric symptoms, diagnoses and work ability were compared in a
quasi-experimental design with those of two short-term therapies and LPP
during a 5-year follow-up from the beginning of the therapies, and PA was
found to be in general more effective than the therapies at the end of the
follow-up (usually the end-point of PA) (Knekt et al., 2011a). Likewise, the
cumulative use of additional psychiatric treatment appeared to be the
lowest in that group (Knekt et al., 2011b). However, in a follow-up ex-
tended beyond the end of PA, the last assessments being either 7 or 10
years after the beginning of treatments, there appeared to be either no or
only small differences between PA and LPP in these outcome domains, one
indicator being a lower level of personality disorder diagnoses in the PA
group at the last, 7-year follow-up (Knekt et al., 2018).
It is not known whether the potentially greater benefits of PA would
also be manifested in other dimensions relevant for personality in-
tegrity and functioning and in improvement of social competences.
Accordingly, we studied the effectiveness of PA and LPP on changes in
personality and social functioning during a 10-year follow-up from the
beginning of the treatments. Our specific hypotheses, based on findings
of previous research and theory (Huber et al., 2013, Knekt et al., 2011a,
Sandell et al., 2000, Busch 2014), were: 1) The quantitative and qua-
litative differences between PA and LPP would be manifested in dif-
ferent types of change patterns especially in the area of personality
functioning. More beneficial changes in personality functioning during
the 10-year follow-up would be expected in the PA group than in the
LPP group, and most likely these benefits would be manifested after the
end-point of PA, i.e. after the 5-year follow-up; 2) More beneficial
changes, respectively, would be expected in social functioning in the PA
group; 3) Due to the relatively good expected outcomes in both treat-
ment groups and significantly greater direct costs of PA, the cost-ef-
fectiveness ratio would be expected to favor LPP over PA.
2. Methods
2.1. Patients and study design
The patient sample of this study consists of persons assigned to long-
term psychodynamic and -analytic treatments provided by the HPS
(Knekt and Lindfors, 2004; Knekt et al., 2011a) (Fig. 1). In the study
altogether 326 of the 459 eligible patients were randomized to two
different types of short-term psychotherapy (n=198) or to long-term
psychodynamic psychotherapy (LPP) (n=128), from 1994 to 2000
(Knekt et al., 2008). In addition 41 patients were pre-screened by the
treating psychoanalyst and self-selected for PA. To be included in the
study, the patients, i.e. 128 patients from LPP and the 41 from PA, were
required to be 20–45 years of age, and to have a long-standing anxiety
or mood disorder causing work dysfunction. Patients with psychotic
disorder, severe personality disorder, adjustment disorder, substance
abuse or organic disorder were excluded. The randomized clinical trial
on effectiveness of LPP in comparison to short-term therapies during a
10-year follow-up has been reported previously (Knekt et al., 2016). In
this cohort study the sample consisted of the patients randomized to
LPP and of those allocated to PA, comprising altogether 169 patients.
After assignment to the treatment group, participation was refused
by 26 patients assigned to LPP and by one patient assigned to PA. Of the
patients starting the assigned therapy, 21 and 5 patients discontinued
the treatment prematurely, respectively. The reasons for discontinuing
the treatment were related to life situations and disappointment with
the treatment. After selection for treatment, the patients were mon-
itored for 10 years. According to the study protocol, patients were
provided with LPP or PA, both followed by no treatment. Written in-
formed consent was obtained from the patients after giving them a
complete description of the study. The study protocol was approved by
the Helsinki University Central Hospital's ethics council.
The mean age of the patients was 32 years (SD=7) and about three
quarters of them were women. Most of the patients (86%) had a diag-
nosis of depressive disorder, about a third (37%) an anxiety disorder
diagnosis, and about one in five had a non-severe personality disorder
(Knekt and Lindfors, 2004). The self-selected PA group differed in some
respects from the LPP group: The proportion of patients with an aca-
demic education was higher in the PA group than in the LPP group, and
they tended to have more anxiety symptoms and comorbidity. How-
ever, characteristics related to psychological suitability, e.g. a global
suitability score, reaction to trial interpretation and motivation for
psychotherapy, were more beneficial in the PA group than in the LPP
group (Table 1) (Knekt et al., 2011a).
2.2. Therapies and therapists
Both treatments were based on variations of the psychoanalytic
theory and technique (e.g. ego psychological, object-relations, self-
psychological and attachment models), and were conducted in ac-
cordance with clinical practice. Accordingly, the therapists personally
modified their interventions during the treatment process according to
the patient's needs within the respective framework, respecting thus
treatment integrity (Knekt et al., 2008; Sandell et al., 2000). Although
LPP and PA are both long-term treatments, they differed markedly by
the mean length of the treatments, 31.3 (SD=11.9) and 56.3
(SD=21.3) months, and by the mean number of sessions, 232 and 646,
respectively (Knekt et al., 2011a). The majority of both treatments
(78% in LPP and 85% in PA) were considered to be adequate in terms of
pre-determined minimum dosage criteria, i.e. at least 120 and 400
sessions – on average twice a week for 1 ½ years in LPP and four ses-
sions a week for 2 ½ years in PA.
LPP is an open-ended, intensive, transference-based therapeutic
approach which helps patients by exploring and working through a
broad area of intrapsychic and interpersonal conflicts. Both inter-
pretative and supportive elements are used. The orientation followed
the clinical principles of LPP (Gabbard, 2004). The frequency of ses-
sions in LPP was 2–3 times a week during approximately 3 years. PA is
an open-ended, highly intensive, transference-based psychodynamic
therapeutic approach which helps patients by thoroughly analyzing and
working through a broad area of intrapsychic and interpersonal con-
flicts. More than LPP, PA aims at increasing the person's self-under-
standing and capacity for self-reflection long after the treatment has
ended (Zerbe, 2007). In variance with LPP, the therapeutic setting and
technique in PA are characterized by greater intensity needed for fa-
cilitating maximum development of transference by the use of couch
and free association for exploring unconscious conflicts, developmental
deficits, and distortions of intrapsychic structures (Greenson, 1985).
The frequency of sessions in PA was 4 times a week during approxi-
mately 5 years.
Altogether 59 therapists carried out the treatments, of whom 29
provided LPP, 18 PA, and 12 both LPP and PA (Knekt et al., 2011a). All
therapists had received standard training in the respective therapy
form. Eligible therapists were also required to have at least 2 years of
experience after completion of their training in the specific treatment
modality provided in the study. The mean number of years of clinical
practice in LPP was 18 among the LPP therapists and in PA 15 years
among those providing PA.
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2.3. Assessments
A semi-structured interview (Knekt and Lindfors, 2004) was used to
identify psychiatric diagnoses of the patients on DSM-IV axes I and II
(American Psychiatric Association, 1994). Information on potential
confounding factors at baseline was gathered by interview, i.e. the
global suitability score of the Suitability for Psychotherapy Scale (SPS
score) and two of its sub-scores, response to trial interpretation and
motivation for psychotherapy (Laaksonen et al., 2012), and the Quality
of Object Relations Scale (QORS) (Azim et al., 1991), by self-reports on
socio-demographic factors, psychiatric symptoms (Symptom Check List
90, Global Severity Index (SCL-90-GSI) (Derogatis et al., 1973), and
with standard outcome measures presented below.
The outcome measures covered the domains of personality and so-
cial functioning. Personality functioning was measured at baseline and
from 4 to 8 times during the 10-year follow-up, using one interview
scale and five scales based on self-report questionnaires. The Level of
Personality Organization (LPO) (Valkonen et al., 2012), based on a
modification of Kernberg's structural interview (Kernberg, 1981), as-
sessed personality organization, i.e. the severity of personality pa-
thology, on a scale varying from 1.0 (normal) to 7.0 (psychotic dis-
order). The 36-item Structural Analysis of Social Behavior self-concept
(introject) questionnaire (SASB) (Benjamin, 1996), is based on a cir-
cumplex model, on which a person's self-concept is summarized and
Fig. 1. Flow-chart of the study.
Table 1
Mean (SD) levels of baseline characteristics of the patients intended to treat.
LPP PA
Characteristic (N=128) (N=41) p-valuea
Socioeconomic variables
Age (years) 31.6 (6.6) 30.4 (5.6) 0.32
Males (%) 21.1 31.7 0.17
Academic education (%) 28.1 46.3 0.03
Employed or student (%) 75.4 87.8 0.13
Psychiatric diagnosis
Depressive disorder (%) 85.9 87.8 0.76
Anxiety disorder (%) 36.7 39.0 0.79
Personality disorder (%) 12.5 19.5 0.27
Psychiatric co-morbidity (%) 36.7 48.8 0.17
Psychiatric history and previous psychiatric treatment
First symptoms at age < 22 years (%) 63.0 55.0 0.37
Psychotherapy (%) 19.0 26.8 0.29
Psychotropic medication (%) 12.8 7.7 0.39
Hospitalization (%) 2.4 0.0 0.32
Suitability for psychotherapy scale (SPS)
Summary score of SPS (% good) 34.4 53.7 0.04
Trial interpretation (% good) 25.8 36.6 0.23
Motivation (% good) 39.0 68.0 < 0.001
a Test for difference between LPP and PA
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described as two vector scores, the horizontal (love–hate) affiliation
(AF) axis and the vertical (emancipation–control) autonomy (AU) axis.
A greater AF score indicates more positive self-concept (‘self-love’) and
a greater AU score a self-concept characterized by a high levels of
emancipation and autonomy. The total score of the 64-item Inventory
of Interpersonal Problems (IIP) reflects the overall level of distress from
interpersonal problems, across eight types of problems: dominancy,
vindictiveness, coldness, social inhibition, non-assertiveness, overly
accommodation, self-sacrificing, and neediness (Horowitz et al., 2000).
Lastly, the immature and the mature defense style scores of the 88-item
Defense Style Questionnaire (DSQ) (Andrews et al., 1989) were as-
sessed. The DSQ measures an individual's relatively stable way to
protect oneself against anxiety and from awareness of internal or ex-
ternal dangers or stressors (Bond, 2004). The immature defense style
score, consisting of 46 items of the 88-item DSQ, was used as the pre-
determined primary indicator of effectiveness in the personality func-
tioning domain.
Social functioning was measured at baseline and 6 to 8 times during
the 10-year follow-up, with four self-report scales. The 54-item Social
Adjustment Scale (SAS-SR) measured functioning on six role areas of
social functioning, work/school/housework, leisure activities, re-
lationships with extended family, couple relationship, as a parent and
as a member of the family unit, and was used as the primary indicator
of effectiveness in the social functioning domain (Weissman and
Bothwell, 1976). A lower SAS-SR score indicated better functioning.
The 29-item Sense of Coherence Scale (SOC) (Antonovsky, 1993)
measured the person's coping capacity as a trust in life being mean-
ingful, manageable and comprehensible, a higher score indicating
better sense of coherence. The 8-item Perceived Competence scale
(Härkäpää, 1995; Wallston, 1990), measured the ability to accomplish
things that are important to one self, a higher score indicating greater
perceived competence. Finally, a generic quality of life scale was in-
cluded, the 20-item Life Situation Survey (LSS) which measured sub-
jective well-being and satisfaction across different areas of life (e.g.
health, economic situation, personal relationships, overall satisfaction
with one's self and life) (Chubon, 1987).
The estimation of direct costs incurred by the treatment of mental
disorders consisted of five different aggregate cost components: 1)
protocol-based and additional LPP and PA sessions, 2) auxiliary psy-
chotherapy sessions (individual short- or long-term therapy, group
therapy, marital or family therapy), 3) outpatient visits due to mental
disorders, 4) psychotropic medication, and 5) inpatient care in hospital
due to mental disorders. Information on the use of psychotropic med-
ication and of hospitalization were based on patient-level registers and
information about the amounts of other services used was obtained
from the patients themselves in yearly inquiries, except the 10-year
inquiry, which covered the three-year period from the 7th to the 10-
year follow-up. All costs were converted to the 2015 price level by using
official price indices estimated by Statistics Finland. When costs were
discounted a three percent yearly discount rate was used. All costs were
included in the analysis in full regardless of the payer. The estimation of
costs is described in more detail in Maljanen et al., (2012).
2.4. Drop-out from assessments
Participation in the assessments during the first five years after
being assigned to treatment was very high, varying from 80% to 90% in
the LPP group and from 85% to 98% in the PA group (Fig. 1). During
the latter part of the follow-up participation decreased only slightly
until the 7-year follow-up, and to a greater degree by the end of the 10-
year follow-up, being still satisfactory, i.e. 66% in LPP and 78% in PA.
2.5. Auxiliary treatment
During the 10-year follow-up 69% in the LPP group and 74% in the
PA group used auxiliary psychiatric treatment, i.e. psychotropic
medication (antidepressive, anxiolytic, antipsychotic and psychiatric
combination drugs), short- or long-term individual or other type of
psychotherapy (various orientations), or in-patient treatment. In both
groups over 50% received psychotropic medication and over 40%
auxiliary psychotherapy. A total of 10% in the LPP and 2% in the PA
group were hospitalized due to psychiatric reasons on some occasion.
2.6. Statistical methods
A cohort study design with repeated measurements was used. The
effectiveness of LPP and PA was compared in an ‘intention-to-treat’
(ITT) design, which included all the patients who had been assigned to
treatment. The primary analyses were based on the assumption of ig-
norable dropouts (Härkänen et al., 2005). The statistical analyses were
based on linear mixed models (Verbeke and Molenberghs, 1997). The
dependent variables were the primary and secondary measures of the
two hypotheses. The pre-determined primary measures were the DSQ
immature defense style score (personality functioning), and SAS-SR
(social functioning). Effect sizes, estimated as model-adjusted mean
differences between LPP and PA using predictive margins, were cal-
culated piecewise for the different time points (Graubard and Korn,
1999; Lee, 1981). The delta method was applied to calculate the con-
fidence intervals for the mean differences (Migon and
Gamerman, 1999). Global statistical significance tests were performed
separately for each of the two hypotheses using the Wald test. Two
primary ITT models were used. The basic model included the main
effects of time, treatment group (LPP and PA), the difference between
theoretical and realized date of measurement, first-order interaction of
time and treatment group, and the outcome variable at baseline. A final
complete model further included covariates (i.e. sex, marital status,
education, currently employed or studying, and the SPS score) which
satisfied the criteria for confounding (Rothman et al., 2008). Ad-
ditionally, the complete model on personality functioning was extended
by including psychiatric symptoms (SCL-90-GSI) as time-dependent
covariate at each time-point, to test whether the differences in the re-
latively stable personality changes remained significant after the ad-
justments.
Complementary ‘as-treated’ (AT) analyses were performed taking
into account violation of the treatment standards. The AT model was
created by completing the complete ITT model with time-dependent
covariates regarding the quality of the protocol-based treatment of the
PA and LPP given (i.e. withdrawal from treatment, waiting time from
baseline examination to the start of study treatment, and discontinua-
tion of study treatment) and use of auxiliary treatment (i.e. additional
psychotherapy, psychotropic medication, and psychiatric hospitaliza-
tion) at baseline and the measurement points during the follow-up.
Since no major differences were found between the ITT and AT models,
the results presented are based on the complete ITT model.
The analyses of costs were based on comparisons of the averages of
different cumulative cost items. Some of the missing values of cost
variables were imputed using the R statistical software (R Core
Team, 2017), and the multiple imputation based on chained equations
and the random forest method implemented in the R packages mice
(van Buuren and Groothuis-Oudshoorn, 2011), miceadds
(Robitzsch et al., 2017) and randomForest (Liaw and Wiener, 2002).
Altogether 50 imputed data sets were generated. Each imputed data set
was then bootstrapped 10 times in order to analyze the cost variables.
All statistical analyses were carried out with SAS software
(SAS Institute Inc., 2011).
3. Results
3.1. Personality functioning
In line with our hypothesis, a statistically significantly different
pattern by time was seen for the primary outcome indicator, immature
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defense style (DSQ) (p=0.002, Fig. 2a) and the secondary indicators,
SASB, AF score (p=0.06, Fig. 2b) and LPO (p=0.008, Fig. 2c) in the
LPP and PA groups (Table 2). All three variables suggested less benefit
from PA during the first years of follow-up and more benefit from the
5th year onwards. In line with our hypothesis, the strongest differences
in favor of PA were seen approximatively 1–2 years after PA had ended
(i.e. at the 6th and/or 7th year of follow-up) for mature defense style
(DSQ), positive self-concept (SASB, AF score), and mature level of
personality organization (LPO). At the final 10-year follow-up point, no
significant differences in effectiveness on personality functioning be-
tween the two treatment groups remained. The differences found re-
mained essentially unchanged after controlling for changes in psy-
chiatric symptoms at the different time points (data not shown).
3.2. Social functioning
In line with our hypothesis, a statistically significantly different
pattern by time was seen for the primary outcome indicator, social
adjustment (SAS-SR) (p=0.004, Fig. 3a) and for all the secondary in-
dicators, SOC (p=0.002, Fig. 3b), Perceived competence (p=0.04,
Fig. 3c), and LSS (p=0.001, Fig. 3d) in the LPP and PA groups
(Table 3). The strongest differences in favor of PA were also seen here at
the 7-year follow-up point, for SAS-SR and SOC, but at the 5-year point
for LSS. Greater early change in Perceived competence in the LPP group
was an exception. In accordance with the findings in personality
functioning, no significant differences in effectiveness between the two
treatment groups remained at the 10-year follow-up point.
3.3. Costs
Due to either no or only minimal differences in the area under the
curve (AUC) estimation of effectiveness (Pruessner et al., 2003) be-
tween the PA and the LPP groups during the entire 10-year follow-up,
i.e. in the mean values of the primary outcome indicators, a thorough
cost-effectiveness analysis was not considered reasonable. However, the
comparison of direct costs of the treatments is considered valuable.
Mainly due to the significantly longer duration and greater frequency of
sessions in PA, the average total undiscounted direct costs (63,034
euros) during the 10-year follow-up were almost three times the level of
persons belonging to the LPP group (22,755 euros) (Fig. 4). Using a
three percent yearly discount rate decreased the total costs to 47,602
and 17,184 euros, respectively. In both groups the majority of the costs
Fig. 2. Change profiles during the 10-year follow-up in DSQ immature defense style (2a), SASB AF (2b), and LPO (2c) scores in LPP and PA.
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Table 2
The mean level of the PA group and score differences (95% confidence interval, CI) between the LPP and the PA groups on personality functioning during the 10-year
follow-up.
LPP PA LPP - PA
Mean score difference (95% CI)
Variable Follow-up (years) N Meana sd N Meana Sd Basic model, unadjustedb Complete model, baseline adjustedc
Personality functioning
DSQ, immature defense style 0 125 3.96 0.06 41 3.77 0.12 0.04 (−0.21, 0.30)
1 94 3.82 0.07 38 3.68 0.13 −0.03 (−0.32, 0.26) 0.04 (−0.22, 0.29)
2 91 3.50 0.08 38 3.56 0.14 −0.24 (−0.55, 0.07) −0.16 (−0.43, 0.11)
3 88 3.40 0.09 34 3.58 0.15 −0.37 (−0.71, −0.02) −0.27 (−0.58, 0.04)
4 89 3.28 0.08 34 3.30 0.15 −0.22 (−0.55, 0.12) −0.14 (−0.43, 0.16)
5 101 3.29 0.09 35 3.07 0.15 0.07 (−0.28, 0.41) 0.11 (−0.17, 0.40)
6 79 3.25 0.09 32 3.01 0.16 0.07 (−0.29, 0.43) 0.14 (−0.17, 0.45)
7 86 3.28 0.09 32 3.05 0.15 0.05 (−0.31, 0.40) 0.12 (−0.18, 0.43)
10 85 3.22 0.09 32 2.96 0.17 0.05 (−0.35, 0.45) 0.13 (−0.23, 0.49)
Change (%) 0–10 18.7 21.5
p-valued 0.002
DSQ, mature defense style 0 125 5.16 0.09 41 5.31 0.17 −0.22 (−0.58, 0.14)
1 94 5.43 0.08 38 5.48 0.14 −0.12 (−0.42, 0.19) −0.07 (−0.34, 0.20)
2 91 5.54 0.09 38 5.77 0.15 −0.30 (−0.65, 0.04) −0.23 (−0.55, 0.09)
3 88 5.74 0.10 34 5.69 0.17 −0.01 (−0.40, 0.37) 0.04 (−0.30, 0.39)
4 89 5.80 0.10 34 5.73 0.17 −0.01 (−0.39, 0.37) 0.05 (−0.32, 0.42)
5 101 5.86 0.10 35 6.07 0.17 −0.26 (−0.65, 0.12) −0.19 (−0.55, 0.16)
6 79 5.61 0.11 33 5.98 0.19 −0.42 (−0.85, 0.02) −0.33 (−0.73, 0.07)
7 86 5.73 0.10 32 6.15 0.17 −0.51 (−0.89, −0.13) −0.42 (−0.80, −0.04)
10 85 5.86 0.11 32 6.03 0.22 −0.23 (−0.71, 0.25) −0.18 (−0.66, 0.30)
Change (%) 0–10 13.6 13.6
p-valued 0.30
SASB, AF score 0 124 7.86 5.15 41 −7.60 9.46 20.6 (0.43, 40.7)
1 93 25.3 6.50 38 9.46 11.0 21.6 (−3.24, 46.3) 1.83 (−18.7, 22.3)
2 89 51.4 6.97 36 35.3 11.8 22.7 (−4.42, 49.8) 2.55 (−20.7, 25.8)
3 89 66.1 7.23 36 36.5 12.5 35.9 (7.88, 63.8) 15.9 (−9.07, 40.9)
4 89 79.8 6.72 34 67.3 11.9 20.6 (−5.87, 46.9) 0.40 (−22.6, 23.4)
5 99 76.6 6.92 35 82.8 12.1 0.88 (−26.2, 28.0) −18.6 (−43.2, 5.97)
6 77 70.2 7.61 32 85.2 13.0 −8.60 (−37.4, 20.2) −28.5 (−55.5,−1.58)
7 86 74.1 7.48 32 96.0 12.7 −16.7 (−45.1, 11.7) −34.5 (−61.7,−7.31)
10 76 85.8 8.07 31 81.6 15.9 8.13 (−28.2, 44.5) −7.84 (−42.8, 27.1)
Change (%) 0–10 37.5 45.8
p-valued 0.06
SASB, AU score 0 124 −29.3 3.25 41 −38.6 5.88 8.78 (−4.03, 21.6)
1 93 −22.5 3.27 38 −26.6 5.51 3.75 (−8.53, 16.0) −1.12 (−11.9, 9.68)
2 89 −11.5 3.53 36 −23.7 5.98 12.5 (−1.02, 26.0) 6.41 (−6.16, 19.0)
3 89 −3.51 4.05 36 −19.3 6.89 15.9 (0.74, 31.1) 9.96 (−4.59, 24.5)
4 89 5.10 3.80 34 −7.57 6.75 15.0 (−0.01, 30.1) 7.55 (−6.95, 22.1)
5 99 3.76 3.63 35 −6.77 6.37 11.0 (−2.80, 24.9) 5.58 (−7.81, 19.0)
6 77 7.50 3.92 32 −4.30 6.69 11.8 (−3.40, 26.9) 5.71 (−8.51, 19.9)
7 86 2.96 4.14 32 1.79 7.01 1.41 (−14.2, 17.0) −4.79 (−19.7, 10.1)
10 76 9.56 4.09 31 −0.58 7.99 9.65 (−8.13, 27.4) 6.98 (−10.8, 24.7)
Change (%) 0–10 22.8 23.6
p-valued 0.41
IIP, total score 0 125 82.9 2.74 41 89.2 5.03 −7.45 (−18.5, 3.59)
1 93 72.5 3.43 38 83.2 5.82 −12.4 (−25.5, 0.68) −6.30 (−16.9, 4.33)
3 88 59.6 3.28 37 67.9 5.66 −10.4 (−22.9, 2.05) −4.68 (−15.8, 6.46)
5 97 54.5 3.47 35 52.4 6.08 0.72 (−13.0, 14.4) 5.25 (−6.92, 17.4)
7 84 54.4 3.65 31 51.3 6.24 1.19 (−12.8, 15.1) 6.79 (−5.28, 18.9)
10 85 49.9 3.65 32 49.4 6.86 −0.24 (−16.2, 15.7) 1.43 (−13.3, 16.2)
Change (%) 0–10 39.8 44.6
p-valued 0.33
LPO 0 128 4.13 0.06 41 4.17 0.10 −0.00 (−0.22, 0.22)
1 99 4.03 0.06 40 4.15 0.10 −0.14 (−0.37, 0.10) −0.06 (−0.26, 0.13)
3 92 3.71 0.09 39 3.92 0.14 −0.23 (−0.58, 0.12) −0.15 (−0.46, 0.15)
5 100 3.72 0.10 38 3.51 0.17 0.16 (−0.24, 0.55) 0.26 (−0.10, 0.62)
7 87 3.65 0.10 37 3.17 0.19 0.37 (−0.07, 0.79) 0.53 (0.12, 0.94)
Change (%) 0–7 11.6 24.0
p-valued 0.008
a The complete intention-to-treat model (ITT), including time, treatment group, the difference between theoretical and realized date of measurement, the first-
order interaction of time and treatment group, and the confounding factors (i.e. sex, marital status, education, currently employed or studying, response to trial
interpretation and motivation for psychotherapy and the SPS score).
b The basic ITT model, i.e. excluding confounding factors, unadjusted for baseline level of the outcome variable considered.
c Complete ITT model further adjusted for the baseline level of the outcome measure considered.
At the underlined entries the differences between the therapy groups are statistically significant (p-values < 0.05), greater effectiveness of PA vs. LPP in italics.
d Global test, p-value for group differences during follow-up.
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(74% and 85%) occurred when the study therapies were in progress, i.e.
during the first three years in the LPP group and during the first five
years in PA. At the 10-year follow-up the average total costs during the
last year were at a comparable level, 949 and 902 euros, in PA and LPP.
Based on the relatively small significant differences in effectiveness
between the therapies and the significantly greater costs of PA, the
latter cannot generally be considered a cost-effective option.
4. Discussion
4.1. Main results
In this study the effectiveness of PA and LPP in the treatment of
patients with depressive or anxiety disorder was compared during a 10-
year follow-up from the beginning of the treatments. It was hypothe-
sized that different types of change patterns would emerge and that PA
would have greater potential than LPP even years after the treatment
had ended, for providing more sustained changes in personality func-
tioning and social functioning. Accordingly, it was found that the
change patterns, indeed, were different. Through the 10-year follow-up,
and specifically from the 5-year to the 7-year follow-up, more
improvement occurred in different aspects of personality functioning
(i.e. mature defense style, self-concept, and level of personality orga-
nization), as well as in social functioning (social adjustment, sense of
coherence and quality of life), in the PA group than in the LPP group.
However, none were sustained until the 10-year follow-up. During the
earlier follow-up occasions when PA was usually still ongoing, practi-
cally all the statistically significant differences favoring LPP by faster
improvement in personality functioning (at the 3-year follow-up when
LPP usually ended) were due to pre-treatment differences between the
groups. These differences appeared to be non-significant when the
confounding was adjusted.
Our finding of PA being more effective in some indicators of per-
sonality and social functioning than LPP up to two years after the
treatment had ended is in line with another cohort study with similar
dosage and length of the treatments, although in this study only limited
significant additional increase of benefits in PA and no decrease in LPP
after the end-point of the treatments were noted (Blomberg et al., 2001;
Sandell et al., 2000). Likewise, our findings concerning more im-
provement in PA than LPP in personality and social functioning and no
significant additional advantage in symptomatic improvement
(Knekt et al., 2018) coincide with the Munich trial findings three years
Fig. 3. Change profiles during the 10-year follow-up in SAS-SR (3a), SOC (3b), Perceived competence (3c), and LSS (3d) scores in LPP and PA.
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after the end of the psychodynamic and -analytic therapies; although, in
that study, both of the long-term therapies were provided with much
fewer sessions and lesser duration (Huber et al., 2013). The present
study thus partially replicated previous evidence of greater effective-
ness of PA in comparison to LPP which manifests years after termina-
tion in the primary target areas of PA. It is also in line with the limited
findings from follow-up studies which indicate that changes in per-
sonality are either stable or increased in PA after it has ended (de Maat
et al., 2013). The finding that the advantage of PA was rather limited
and was diluted at the final 10-year follow-up, partly due to additional
positive change happening in the LPP group, was unexpected and re-
quires additional research on the determinants of changes in the three
last years of the follow-up. The modesty of the differences is important
from a clinical point of view, as the duration and dosage of the treat-
ments differ greatly. Accordingly, the relatively high dosage of LPP
used in this study may indicate that for many patients it is as sufficient
as the much higher dosage of PA in enabling continued post-treatment
improvement.
The specificity of the additional benefits of PA in personality and
social functioning highlight the importance of the treatment time frame
in achieving functional accomplishments, as suggested previously in
cohort studies focusing on the length of treatment necessary for pro-
viding recovery in personality-related problems (Kopta et al., 1994;
Perry et al., 1999). Likewise, the specificity of the PA benefits can be
put into perspective when compared to the difference between LPP and
short-term treatments during a 10-year follow-up, which showed
greater benefits in LPP in symptoms but no difference in personality and
social functioning (Knekt et al., 2016). As PA in this study had both a
higher dosage and greater intensity than LPP and may have differed by
a more pronounced use of some psychoanalytic techniques, like insight-
oriented exploration of the patient's wishes, dreams and fantasies from
it, it is not known which aspects of the PA treatments were responsible
for the extended results in personality and social functioning – and
which aspects of both treatments were crucial for the relatively small
differences between them. Although purely greater extent of psycho-
analytic techniques have previously been suggested to be associated
with greater benefits in PA (Zimmermann et al., 2015), their skillful
use, e.g. well-timed interpretations, sensitive integration to the patient's
present life experiences and realities, in combination with the quality of
the therapeutic relation, and the fit between patient and therapist
Table 3
The mean level of the PA group and score differences (95% confidence interval, CI) between the LPP and the PA groups on social functioning during the 10-year
follow-up.
LPP PA LPP - PA
Mean score difference (95% CI)
Variable Follow-up (years) N Meana sd N Meana Sd Basic model, unadjustedb Complete model, baseline adjustedc
Social functioning
SAS-SR 0 125 2.19 0.04 41 2.27 0.07 −0.09 (−0.23, 0.05)
1 94 2.04 0.04 38 2.06 0.06 −0.05 (−0.19, 0.10) 0.01 (−0.12, 0.14)
2 90 1.94 0.04 38 2.00 0.07 −0.09 (−0.24, 0.07) −0.02 (−0.17, 0.12)
3 89 1.84 0.04 36 1.99 0.07 −0.18 (−0.33, −0.02) −0.11 (−0.27, 0.04)
4 88 1.84 0.04 34 1.77 0.07 0.04 (−0.01, 0.19) 0.11 (−0.04, 0.25)
5 100 1.83 0.04 35 1.77 0.07 0.03 (−0.13, 0.19) 0.09 (−0.06, 0.25)
6 79 1.88 0.05 33 1.80 0.08 0.05 (−0.12, 0.23) 0.13 (−0.03, 0.29)
7 86 1.87 0.04 32 1.74 0.07 0.11 (−0.06, 0.27) 0.17 (0.01, 0.33)
10 85 1.75 0.05 32 1.79 0.09 −0.05 (−0.27, 0.16) −0.02 (−0.22, 0.18)
Change (%) 0–10 20.1 21.1
p-valued 0.004
SOC 0 125 113 1.86 41 108 3.41 7.24 (−0.12, 14.6)
1 94 119 2.31 38 118 3.91 4.49 (−4.30, 13.3) −2.96 (−10.7, 4.76)
3 89 134 2.55 36 126 4.35 11.7 (1.81, 21.5) 3.80 (−5.36, 13.0)
5 100 139 2.38 35 141 4.18 0.74 (−8.76, 10.2) −6.31 (−14.7, 2.07)
7 86 137 2.81 32 145 4.76 −4.97 (−15.6, 5.62) −12.2 (−22.3, −2.08)
10 85 139 2.96 32 144 5.68 −2.37 (−15.0, 10.3) −9.13 (−20.9, 2.59)
Change (%) 0–10 23.0 33.3
p-valued 0.002
Perceived competence 0 126 30.1 0.60 41 28.8 1.09 1.34 (−1.01, 3.74)
1 105 32.6 0.70 38 30.6 1.23 2.41 (−0.43, 5.25) 2.01 (−0.37, 4.37)
2 97 34.6 0.70 36 32.3 1.22 2.80 (−0.10, 5.70) 2.17 (−0.36, 4.70)
3 99 36.1 0.76 36 33.0 1.35 3.49 (0.38, 6.60) 2.92 (0.05, 5.80)
4 101 37.3 0.68 34 35.5 1.27 2.39 (−0.45, 5.23) 1.78 (−1.05, 4.62)
5 100 36.7 0.70 35 37.8 1.24 −0.57 (−3.42, 2.29) −1.22 (−3.97, 1.54)
6 87 36.5 0.81 34 37.3 1.41 −0.33 (−3.52, 2.89) −0.89 (−3.84, 2.06)
7 96 36.8 0.72 33 37.7 1.27 −0.59 (−3.52, 2.35) −0.84 (−3.73, 2.05)
Change (%) 0–7 22.3 30.9
p-valued 0.04
LSS 0 125 78.1 1.59 41 75.9 2.91 1.13 (−5.14, 7.39)
1 93 87.4 1.95 38 85.0 3.27 1.83 (−5.67, 9.32) 0.90 (−6.35, 8.14)
3 88 100 2.33 37 94.8 3.91 4.99 (−4.05, 14.0) 3.89 (−4.77, 12.5)
5 99 101 2.17 35 109 3.78 −8.45 (−17.1, 0.16) −9.57 (−17.4, −1.74)
7 86 101 2.43 32 107 4.11 −7.23 (−16.6, 2.14) −8.08 (−16.9, 0.77)
Change (%) 0–10 29.3 41.0
p-valued 0.001
a The complete intention-to-treat model (ITT), including time, treatment group, the difference between theoretical and realized date of measurement, the first-
order interaction of time and treatment group, and the confounding factors (i.e. sex, marital status, education, currently employed or studying, response to trial
interpretation and motivation for psychotherapy and the SPS score).
b The basic ITT model, i.e. excluding confounding factors, unadjusted for baseline level of the outcome variable considered.
c Complete ITT model further adjusted for the baseline level of the outcome measure considered.
At the underlined entries the differences between the therapy groups are statistically significant (p-values < 0.05), greater effectiveness of PA vs. LPP in italics.
d Global test, p-value for group differences during follow-up.
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(Bush and Meehan, 2011) might also be relevant. Accordingly, further
research focused on the importance of treatment duration, session fre-
quency and different aspects of the treatment process, as well as factors
related to patient and therapist characteristics, are needed to in-
vestigate their impact on the different outcome dimensions.
From a cost-effectiveness and public health perspective, the almost
three times higher direct costs of PA than LPP and its relatively limited
additional long-term benefits in the outcome dimensions assessed do
not favor its use as a standard treatment in this patient population.
4.2. Methodological considerations
There are several strengths of the study design and its methods,
discussed in greater detail elsewhere (Knekt et al., 2011a, b). First, a
cohort of outpatients with similar inclusion and exclusion criteria was
selected for this comparative cohort study, the patients were followed
throughout an exceptionally long follow-up with repeated measure-
ments covering different aspects of the outcome domains, which were
relevant for aims of both treatments. Second, the participation per-
centage was relatively high in both groups up to the 7-year follow-up,
and only slightly decreased by the final 10-year follow-up. Third, even
though there were some differences in the pre-treatment characteristics
of the patients self-selected to PA and those randomized to LPP, ad-
justment for potential confounding factors was used in the statistical
analyses to reduce potential bias due to selection. Fourth, information
on auxiliary treatment and use of national health register data con-
cerning all patients was gathered and acknowledged in the AT analyses
which complemented the basic ITT analyses. Fifth, both LPP and PA
were carried out as in normal clinical practice, with no manualization,
allowing greater external validity and generalizability due to flexible
use of psychoanalytic and -dynamic techniques.
There are several factors which may complicate the interpretation of
the results and thus need to be taken into consideration. First, as there
was no adherence monitoring of the therapies, it is not known to what
extent the treatments were carried out as intended (apart from external
criteria which were monitored) and competently by the therapists.
However, all the therapists were trained according to the method they
practiced in the study, had a long clinical experience, and, in a study on
therapist characteristics, were found to be generally comparable in
their self-rated work involvement (Heinonen et al., 2014). Second, in
the LPP group about a fifth of the patients withdrew before being as-
signed to therapy, in comparison to only one patient in the PA group.
This fact, in addition to that only PA patients were selected on the basis
of being suitable for the treatment, reflect differences in the referral
practices and in personal commitment to therapy which may have an
influence on the results. However, the differences in the pre-treatment
characteristics of the patients were rather small and were accounted for
in the statistical models (Knekt et al., 2011a). Third, due to the ex-
ceptionally long follow-up, dropout from measurements increased from
the 7-year to the 10-year follow-up and thus the missing observations
also inevitably increased the uncertainty of the results. Fourth, the
small sample size in the PA group limits the ability to detect true dif-
ferences even if there are those. Fifth, some of the outcome measures
were not available at the 10-year follow-up, e.g. the interview measure
LPO, which might have given additional information on the relatively
stable ‘structural change’ of personality at the final follow-up. However,
the primary indicator DSQ was available and also covered trait-like
aspects of personality (Bond, 2004). The fact that the differences in DSQ
remained unchanged after controlling for co-occurring changes in
psychiatric symptoms, suggests that they were not only due to im-
proved state of mental wellbeing. Sixth, although the patients at base-
line had relatively persistent depressive or anxiety disorders, the rate of
personality disorders was low. This limits the generalizability of the
findings on the effectiveness of psychoanalytic treatments in more
complex psychiatric disorders. However, it also highlights the im-
portance of the several statistically significant findings observed.
4.3. Conclusions
PA may be considered as a viable treatment option for patients
when long-term aims related to personality and social functioning are
essential and when shorter and less intensive treatments are not con-
sidered to be sufficient. Greater direct costs of PA limit its feasibility in
a public health setting. For developing more sophisticated selection
criteria for PA, additional research on the impact of individual patient
and alliance factors on outcome is needed, extended with comparative
qualitative analysis of successful and unsuccessful treatments.
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